Found: 47
Select item for more details and to access through your institution.
A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2005, v. 131, n. 3, p. 147, doi. 10.1007/s00432-004-0626-z
- By:
- Publication type:
- Article
Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1261, doi. 10.1093/jjco/hyab072
- By:
- Publication type:
- Article
Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1269, doi. 10.1093/jjco/hyab084
- By:
- Publication type:
- Article
Skin problems and EGFR-tyrosine kinase inhibitor.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 4, p. 291, doi. 10.1093/jjco/hyv207
- By:
- Publication type:
- Article
A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 9, p. 5237, doi. 10.1007/s00520-021-06092-1
- By:
- Publication type:
- Article
Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
- Published in:
- Nucleic Acids Research, 2017, v. 45, n. 10, p. 5995, doi. 10.1093/nar/gkx325
- By:
- Publication type:
- Article
Casein kinase I δ/ɛ phosphorylates topoisomerase IIα at serine-1106 and modulates DNA cleavage activity.
- Published in:
- Nucleic Acids Research, 2009, v. 37, n. 2, p. 382
- By:
- Publication type:
- Article
Early administration of durvalumab after chemoradiotherapy increased risk of pneumonitis in patients with locally advanced non‐small cell lung cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 2, p. e111, doi. 10.1111/ajco.13803
- By:
- Publication type:
- Article
A phase I/II trial of weekly nab‐paclitaxel for pretreated non‐small‐cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 4, p. 250, doi. 10.1111/ajco.13147
- By:
- Publication type:
- Article
Phase I dose-escalation study evaluating safety, tolerability and pharmacokinetics of MEDI-573, a dual IGF-I/II neutralizing antibody, in Japanese patients with advanced solid tumours.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 194, doi. 10.1007/s10637-014-0170-x
- By:
- Publication type:
- Article
Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 79, doi. 10.1007/s10147-022-02266-x
- By:
- Publication type:
- Article
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 7, p. 1139, doi. 10.1007/s10147-022-02164-2
- By:
- Publication type:
- Article
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 7, p. 731, doi. 10.1007/s10147-019-01431-z
- By:
- Publication type:
- Article
Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 70, doi. 10.1007/s10147-016-1039-0
- By:
- Publication type:
- Article
Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.
- Published in:
- Clinical Lung Cancer, 2019, v. 20, n. 2, p. 134, doi. 10.1016/j.cllc.2018.10.008
- By:
- Publication type:
- Article
Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Study Protocol: Phase-Ib Trial of Nivolumab Combined With Metformin for Refractory/Recurrent Solid Tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non-Small-Cell Lung Cancer: Study Protocol.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non—Small-Cell Lung Cancer: Study Protocol.
- Published in:
- Clinical Lung Cancer, 2017, v. 18, n. 1, p. 92, doi. 10.1016/j.cllc.2016.06.014
- By:
- Publication type:
- Article
Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity of the enzyme: Identification based on artifactual +80-Da modification at this site.
- Published in:
- Proteomics, 2011, v. 11, n. 5, p. 829, doi. 10.1002/pmic.201000194
- By:
- Publication type:
- Article
Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) After EGFR-TKI-Induced Interstitial Lung Disease (CS-Lung-005).
- Published in:
- Lung, 2024, v. 202, n. 1, p. 63, doi. 10.1007/s00408-023-00669-9
- By:
- Publication type:
- Article
Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 18, p. 6597, doi. 10.1002/cam4.3306
- By:
- Publication type:
- Article
Radiation-induced enterocolitis after combination therapy with palliative radiotherapy and immune checkpoint inhibitors in patients with metastatic lung cancer.
- Published in:
- Experimental & Therapeutic Medicine, 2022, v. 23, n. 5, p. N.PAG, doi. 10.3892/etm.2022.11266
- By:
- Publication type:
- Article
Treatment patterns and clinical outcomes of resectable clinical stage III non‐small cell lung cancer in a Japanese real‐world setting: Surgery cohort analysis of the SOLUTION study.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 20, p. 1541, doi. 10.1111/1759-7714.15305
- By:
- Publication type:
- Article
An easy tool to predict survival in patients with bone metastatic lung cancer treated with palliative radiotherapy.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 19, p. 1795, doi. 10.1111/1759-7714.14903
- By:
- Publication type:
- Article
Crizotinib for recurring non‐small‐cell lung cancer with EML4‐ALK fusion genes previously treated with alectinib: A phase II trial.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 5, p. 643, doi. 10.1111/1759-7714.13825
- By:
- Publication type:
- Article
Novel prospective umbrella‐type lung cancer registry study for clarifying clinical practice patterns: CS‐Lung‐003 study protocol.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 5, p. 725, doi. 10.1111/1759-7714.13789
- By:
- Publication type:
- Article
A phase II study of topotecan and cisplatin with sequential thoracic radiotherapy in elderly patients with small-cell lung cancer: Okayama Lung Cancer Study Group 0102.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 943, doi. 10.1007/s00280-014-2425-9
- By:
- Publication type:
- Article
A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 1, p. 53, doi. 10.1007/s00280-006-0346-y
- By:
- Publication type:
- Article
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 3, p. 230, doi. 10.1007/s00280-004-0826-x
- By:
- Publication type:
- Article
Clinical features and treatment of epidermal growth factor inhibitor‐related late‐phase papulopustular rash.
- Published in:
- Journal of Dermatology, 2020, v. 47, n. 2, p. 121, doi. 10.1111/1346-8138.15170
- By:
- Publication type:
- Article
Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 3, p. 249, doi. 10.1080/0284186X.2019.1695062
- By:
- Publication type:
- Article
Long-term follow-up of phase II trial of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer.
- Published in:
- Acta Oncologica, 2012, v. 51, n. 4, p. 537, doi. 10.3109/0284186X.2011.631580
- By:
- Publication type:
- Article
Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Factors affecting the local control of stereotactic body radiotherapy for lung tumors including primary lung cancer and metastatic lung tumors.
- Published in:
- Japanese Journal of Radiology, 2012, v. 30, n. 5, p. 430, doi. 10.1007/s11604-012-0071-x
- By:
- Publication type:
- Article
Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemoradiotherapy.
- Published in:
- Japanese Journal of Radiology, 2012, v. 30, n. 3, p. 249, doi. 10.1007/s11604-011-0040-9
- By:
- Publication type:
- Article
Local control of bone metastasis treated with palliative radiotherapy in patients with lung cancer: An observational retrospective cohort study.
- Published in:
- Oncology Letters, 2023, v. 26, n. 1, p. N.PAG, doi. 10.3892/ol.2023.13889
- By:
- Publication type:
- Article
Early response of bone metastases can predict tumor response in patients with non-small-cell lung cancer with bone metastases in the treatment with nivolumab.
- Published in:
- Oncology Letters, 2020, v. 20, n. 3, p. 2977, doi. 10.3892/ol.2020.11856
- By:
- Publication type:
- Article
Impact of digital positron emission tomography/computed tomography on the delineation of clinical target volume in advanced lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2023, v. 19, n. 6, p. N.PAG, doi. 10.3892/mco.2023.2698
- By:
- Publication type:
- Article
Long‐term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study.
- Published in:
- Cancer Science, 2024, v. 115, n. 4, p. 1296, doi. 10.1111/cas.16107
- By:
- Publication type:
- Article
Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Science, 2019, v. 110, n. 5, p. 1715, doi. 10.1111/cas.14003
- By:
- Publication type:
- Article
Impact of neutrophil-to-lymphocyte ratio throughout the course of chemoradiotherapy on overall survival and distant failure in unresectable stage III non-small cell lung cancer.
- Published in:
- Japanese Journal of Radiology, 2021, v. 39, n. 9, p. 914, doi. 10.1007/s11604-021-01129-1
- By:
- Publication type:
- Article